Home 2022 Volume 107, Issue 1-2

2022 Volume 107, Issue 1-2

Curcumin and Its Analogs as Potential Epigenetic Modulators: Prevention of Diabetes and Its Complications 
Subject Area:  Pharmacology
Chunyin Tang; Yantao Liu; Shilin Liu; Chunsong Yang; Li Chen; Fengru Tang; Fang Wang; Lin Zhan; Hong Deng; Wei Zhou; Yunzhu Lin; Xiaohuan Yuan
Pharmacology (2022) 107 (1-2): 1–13.
Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway 
Subject Area:  Pharmacology
Yi Chu; Jiwei Teng; Pin Feng; Hui Liu; Fangfang Wang; Haiyan Wang
Pharmacology (2022) 107 (1-2): 14–27.
5-Aminosalicylic Acid, A Weak Agonist for Aryl Hydrocarbon Receptor That Induces Splenic Regulatory T Cells 
Subject Area:  Pharmacology
Atsuhito Kubota; Masaru Terasaki; Rie Takai; Masaki Kobayashi; Ryuta Muromoto; Hiroyuki Kojima
Pharmacology (2022) 107 (1-2): 28–34.
Effect of Mineralocorticoid Receptor Antagonists on the Prognosis of Patients with Ventricular Tachyarrhythmias 
Subject Area:  Pharmacology
Tobias Schupp; Max von Zworowsky; Linda Reiser; Mohammad Abumayyaleh; Kathrin Weidner; Kambis Mashayekhi; Thomas Bertsch; Mohammed L. Abba; Ibrahim Akin; Michael Behnes
Pharmacology (2022) 107 (1-2): 35–45.
Effects of Increased Central Cholinergic Activity on the Metabolic Challenge Induced by Submaximal Exercise in Rats: Adrenomedullary Secretion Influences 
Subject Area:  Pharmacology
Alex Guazzi Rodrigues; Helton Oliveira Campos; Lucas Rios Drummond; Umeko Marubayashi; Cândido Celso Coimbra
Pharmacology (2022) 107 (1-2): 46–53.
Pregnane-Oximino-Alkyl-Amino-Ether Compound as a Novel Class of TGR5 Receptor Agonist Exhibiting Antidiabetic and Anti-Dyslipidemic Activities 
Subject Area:  Pharmacology
Jyoti Gupta; Dharmendra P. Singh; Prem C. Verma; Neha Rahuja; Rohit Srivastava; Ishbal Ahmad; Natasha Jaiswal; Harish Kumar; Anand P. Gupta; Varsha Gupta; Anamika Misra; Hari N. Kushwaha; Bhawani Singh; Sheo K. Singh; Anil K. Dwivedi; Jiaur R. Gayen; Sabyasachi Sanyal; Arvind K. Srivastava; Ram Pratap; Akhilesh K. Tamrakar
Pharmacology (2022) 107 (1-2): 54–68.
Effects of Fatty Acid Amide Hydroxylase Inhibitor URB597 on the Catecholaminergic Activity of the Adrenal Medulla in Stressed Male and Female Rats 
Subject Area:  Pharmacology
Harisa Ferizovic; Natasa Spasojevic; Milica Jankovic; Bojana Stefanovic; Sladjana Dronjak
Pharmacology (2022) 107 (1-2): 81–89.
A Novel Partial PPARγ Agonist Has Weaker Lipogenic Effect in Adipocytes and Stimulates GLUT4 Translocation in Skeletal Muscle Cells via AMPK-Dependent Signaling 
Subject Area:  Pharmacology
Bhavimani Guru; Akhilesh K. Tamrakar; Subhankar P. Mandal; Prashantha B.R. Kumar; Aditya Sharma; Santhepete Nanjundaiah Manjula
Pharmacology (2022) 107 (1-2): 90–101.
Impact of Ghrelin on Ventricular Arrhythmia and Related Mechanism After Myocardial Infarction 
Subject Area:  Pharmacology
Zhengtao Hu; Ting Zhang; Yong Mei; Nan Sun; Kun Lv; Deguo Wang
Pharmacology (2022) 107 (1-2): 102–110.
Assessment of Drug Interactions with Online Electronic Checkers in Multi-Pathological Patients 
Subject Area:  Pharmacology
Bernardino Roca; Manuel Roca
Pharmacology (2022) 107 (1-2): 111–115.
Validation of Fenoterol to Study β2-Adrenoceptor Function in the Rat Urinary Bladder 
Subject Area:  Pharmacology
Betül Rabia Erdogan; Zeynep Elif Yesilyurt; Ebru Arioglu-Inan; Martin Christian Michel
Pharmacology (2022) 107 (1-2): 116–121.

Editor’s choice

A Risk-Prediction Nomogram for Neutropenia or Febrile Neutropenia after Etoposide-Based Chemotherapy in Cancer Patients: A Retrospective Cohort Study 
Subject Area:  Pharmacology
Yu Zhu; Daihong Guo; Xianghao Kong; Siyuan Liu; Chengxuan Yu
Pharmacology (2022) 107 (1-2): 69–80.